Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
Impact of Direct Current Neuromuscular Electrical Stimulation on Physical Therapy Treatment of Peripheral Neuropathy
1 other identifier
interventional
148
1 country
11
Brief Summary
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 1, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2023
CompletedMay 25, 2023
May 1, 2023
10 months
June 28, 2022
May 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Distal Latency
The time in milliseconds that it takes the impulse to travel from the stimulation point at the wrist to the recording electrode.
Pre-intervention
Distal Latency
The time in milliseconds that it takes the impulse to travel from the stimulation point at the wrist to the recording electrode.
6 weeks
Tibial Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Tibial Motor Nerve.
Pre-intervention
Tibial Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Tibial Motor Nerve.
6 weeks
Fibular Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Fibular Motor Nerve.
6 weeks
Fibular Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Fibular Motor Nerve.
Pre-intervention
Ulnar Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Ulnar Motor Nerve.
Pre-intervention
Ulnar Motor Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Ulnar Motor Nerve.
6 weeks
Sural Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Sural Sensory Nerve.
Pre-intervention
Sural Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Sural Sensory Nerve.
6 weeks
Superficial Fibular Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Superficial Fibular Sensory Nerve.
6 weeks
Superficial Fibular Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Superficial Fibular Sensory Nerve.
Pre-intervention
Ulnar Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Ulnar Sensory Nerve.
Pre-intervention
Ulnar Sensory Nerve Conduction Velocity
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Ulnar Sensory Nerve.
6 weeks
Tibial F-Wave
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Tibial F-Wave.
Pre-intervention
Tibial F-Wave
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the Tibial F-Wave.
6 weeks
H-Reflex
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the H-Reflex.
6 weeks
H-Reflex
Electrodes on the skin release tiny electric shocks to stimulate nerves; the amplitude of the nerve signal will be measured for the H-Reflex.
Pre-intervention
Study Arms (2)
Neubie Direct Current Electrical Stimulation
EXPERIMENTALThe experimental group subjects follow with 12 sessions of physical therapy over a 6-week period which include: a 30-min foot bath session using the Neubie and 15-min of various physical therapy exercises.
Transcutaneous Electrical Nerve Stimulation
OTHERThe control group subjects follow with 12 sessions of physical therapy over a 6-week period which include: a 30-min footbath with TENS and 15-min of various physical therapy exercises.
Interventions
Direct Current Electrical Stimulation Device that uses electrodes non-invasively on the skin to stimulate muscle fibers.
Transcutaneous Electrical Nerve Stimulation device - uses alternating current delivered through electrodes on the skin.
Eligibility Criteria
You may qualify if:
- Must have a minimum score of 1 on the modified Toronto Clinical Neuropathy Score
- Must be able to attend weekly sessions for the 6 week period of the study (no extended travel)
- Must be at least 18 years old.
You may not qualify if:
- Currently pregnant
- Cardiac pacemaker
- Active or recent cancer in the lower limbs
- Active or recent blood clots in the lower limbs
- History of epilepsy
- No open wounds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
APEX Physical Therapy
Cape Coral, Florida, 33991, United States
Catalyst Physical Therapy
Clearwater, Florida, 33756, United States
APEX Physical Therapy
Fort Myers, Florida, 33908, United States
Diagnostic Solutions
Springfield, Kentucky, 40069, United States
Hands-On Physical Therapy
Astoria, New York, 11106, United States
Hands-On Physical Therapy of Queens Village
Queens Village, New York, 11428, United States
Panetta Physical Therapy & Diagnostics
Ronkonkoma, New York, 11779, United States
Courcier Physical Therapy
Edmond, Oklahoma, 73013, United States
Spine & Rehab Specialists
El Paso, Texas, 79936, United States
Active Fitness Physical Therapy
Oak Hill, West Virginia, 25901, United States
Active Fitness Physical Therapy
Victor, West Virginia, 25938, United States
Related Publications (19)
Snyder MJ, Gibbs LM, Lindsay TJ. Treating Painful Diabetic Peripheral Neuropathy: An Update. Am Fam Physician. 2016 Aug 1;94(3):227-34.
PMID: 27479625BACKGROUNDRogers LC, Andros G, Armstrong DG. Update from the Diabetic Foot Global Conference (DFCon) 2007. Int Wound J. 2007 Dec;4(4):295-7. doi: 10.1111/j.1742-481X.2007.00377.x. No abstract available.
PMID: 18154623BACKGROUNDThakral G, Kim PJ, LaFontaine J, Menzies R, Najafi B, Lavery LA. Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy. J Diabetes Sci Technol. 2013 Sep 1;7(5):1202-9. doi: 10.1177/193229681300700510.
PMID: 24124947BACKGROUNDZiegler D. Treatment of diabetic polyneuropathy: Update 2006. Ann N Y Acad Sci. 2006 Nov;1084:250-66. doi: 10.1196/annals.1372.008.
PMID: 17151306BACKGROUNDSluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21. doi: 10.1054/jpai.2003.434.
PMID: 14622708BACKGROUNDPeters EJ, Armstrong DG, Wunderlich RP, Bosma J, Stacpoole-Shea S, Lavery LA. The benefit of electrical stimulation to enhance perfusion in persons with diabetes mellitus. J Foot Ankle Surg. 1998 Sep-Oct;37(5):396-400; discussion 447-8. doi: 10.1016/s1067-2516(98)80048-3.
PMID: 9798171BACKGROUNDGilcreast DM, Stotts NA, Froelicher ES, Baker LL, Moss KM. Effect of electrical stimulation on foot skin perfusion in persons with or at risk for diabetic foot ulcers. Wound Repair Regen. 1998 Sep-Oct;6(5):434-41. doi: 10.1046/j.1524-475x.1998.60505.x.
PMID: 9844163BACKGROUNDda Silva MP, Liebano RE, Rodrigues VA, Abla LE, Ferreira LM. Transcutaneous electrical nerve stimulation for pain relief after liposuction: a randomized controlled trial. Aesthetic Plast Surg. 2015 Apr;39(2):262-9. doi: 10.1007/s00266-015-0451-6. Epub 2015 Feb 10.
PMID: 25665520BACKGROUNDOrdog GJ. Transcutaneous electrical nerve stimulation versus oral analgesic: a randomized double-blind controlled study in acute traumatic pain. Am J Emerg Med. 1987 Jan;5(1):6-10. doi: 10.1016/0735-6757(87)90281-6.
PMID: 3545246BACKGROUNDZhao M, Bai H, Wang E, Forrester JV, McCaig CD. Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signaling through VEGF receptors. J Cell Sci. 2004 Jan 26;117(Pt 3):397-405. doi: 10.1242/jcs.00868. Epub 2003 Dec 16.
PMID: 14679307BACKGROUNDKanno S, Oda N, Abe M, Saito S, Hori K, Handa Y, Tabayashi K, Sato Y. Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation. 1999 May 25;99(20):2682-7. doi: 10.1161/01.cir.99.20.2682.
PMID: 10338463BACKGROUNDReichstein L, Labrenz S, Ziegler D, Martin S. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia. 2005 May;48(5):824-8. doi: 10.1007/s00125-005-1728-0. Epub 2005 Apr 14.
PMID: 15830180BACKGROUNDDeSantana JM, Walsh DM, Vance C, Rakel BA, Sluka KA. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep. 2008 Dec;10(6):492-9. doi: 10.1007/s11926-008-0080-z.
PMID: 19007541BACKGROUNDDoucet BM, Griffin L. High-versus low-frequency stimulation effects on fine motor control in chronic hemiplegia: a pilot study. Top Stroke Rehabil. 2013 Jul-Aug;20(4):299-307. doi: 10.1310/tsr2004-299.
PMID: 23893829BACKGROUNDNajafi B, Talal TK, Grewal GS, Menzies R, Armstrong DG, Lavery LA. Using Plantar Electrical Stimulation to Improve Postural Balance and Plantar Sensation Among Patients With Diabetic Peripheral Neuropathy: A Randomized Double Blinded Study. J Diabetes Sci Technol. 2017 Jul;11(4):693-701. doi: 10.1177/1932296817695338. Epub 2017 Feb 1.
PMID: 28627217BACKGROUNDChandrasekaran S, Davis J, Bersch I, Goldberg G, Gorgey AS. Electrical stimulation and denervated muscles after spinal cord injury. Neural Regen Res. 2020 Aug;15(8):1397-1407. doi: 10.4103/1673-5374.274326.
PMID: 31997798BACKGROUNDZehr EP, Collins DF, Chua R. Human interlimb reflexes evoked by electrical stimulation of cutaneous nerves innervating the hand and foot. Exp Brain Res. 2001 Oct;140(4):495-504. doi: 10.1007/s002210100857.
PMID: 11685403BACKGROUNDYang, Z. et al. Scoring systems to screen for diabetic peripheral neuropathy. (Cochrane Database Syst Rev. 2018 Jul 30;2018(7):CD010974. doi: 10.1002/14651858.CD010974.pub2. eCollection 2018 Jul.).
RESULTKostopoulos D, Rizopoulos K, McGilvrey J, Hauskey J, Courcier J, Connor-Israel K, Koster H, von Leden R. An Open-Label Comparative Study of the Impact of Two Types of Electrical Stimulation (Direct Current Neuromuscular Electrical Stimulation and Transcutaneous Electrical Stimulation) on Physical Therapy Treatment of Diabetic Peripheral Neuropathy. J Diabetes Res. 2025 Feb 4;2025:9970124. doi: 10.1155/jdr/9970124. eCollection 2025.
PMID: 39949402DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ramona von Leden, PhD
NeuFit - Neurological Fitness and Education
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes will be assessed by clinicians at Hands on Diagnostics locations. Assessors will be blinded to which intervention participant has received.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 1, 2022
Study Start
August 1, 2022
Primary Completion
May 20, 2023
Study Completion
May 20, 2023
Last Updated
May 25, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share